PERSPECTA

News from every angle

Back to headlines

Marinomed to File for Insolvency Proceedings Due to Unpaid Debts

Austrian biotech company Marinomed announced its intention to file for insolvency proceedings without self-administration, citing the inability to implement its restructuring plan due to missing payments from Unither for the sale of its Carragelose business.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.